Related Experiment Video
Updated: Nov 5, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Inflammation and Oxidative Stress in Chronic Kidney Disease and Dialysis Patients
Thomas Ebert1, Ognian Neytchev2, Anna Witasp1
1Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Insights
Chronic kidney disease (CKD) involves inflammation and oxidative stress, similar to aging. Systemic interventions targeting these processes may improve health span and reduce CKD burden.
Area of Science:
- Nephrology
- Gerontology
- Oxidative Stress Research
Background:
- Chronic kidney disease (CKD) is a lifestyle disease linked to aging, characterized by inflammation, oxidative stress, vascular aging, and cellular senescence.
- A systemic approach to mitigate these adverse components offers potential to attenuate CKD effects and associated morbidities.
- Interventions like pharmacological, nutritional, and lifestyle changes are explored to manage CKD.
Purpose of the Study:
- To review current concepts of inflammation and oxidative damage as key CKD pathomechanisms.
- To discuss the beneficial and adverse effects of various systemic interventions in CKD patients.
- To explore novel therapeutic avenues for reducing CKD burden and improving patient outcomes.
Main Methods:
- Review of current literature on inflammation and oxidative stress in CKD.
- Analysis of systemic interventions including senotherapeutics, NRF2-KEAP1 pathway modulators, klotho axis, SGLT2 inhibitors, and live bio-therapeutics.
- Discussion of potential benefits and risks associated with these interventions.
Main Results:
- Inflammation and oxidative stress are central pathomechanisms in CKD.
- Several interventions show promise in mitigating CKD progression and related complications.
- Specific pathways and agents like senotherapeutics, NRF2-KEAP1, klotho axis, SGLT2 inhibitors, and live bio-therapeutics are highlighted for their potential.
Conclusions:
- Systemic interventions targeting inflammation, oxidative stress, and cellular senescence can potentially attenuate CKD progression and associated morbidities.
- Senotherapeutics, NRF2-KEAP1 pathway, klotho axis, SGLT2 inhibitors, and live bio-therapeutics represent promising strategies to improve quality of life, morbidity, and mortality in CKD patients.
- A comprehensive approach is needed to manage the complex burden of CKD and enhance health span in this patient group.
Abstract:
Chronic kidney disease (CKD) can be regarded as a burden of lifestyle disease that shares common underpinning features and risk factors with the aging process; it is a complex constituted by several adverse components, including chronic inflammation, oxidative stress, early vascular aging, and cellular senescence. A systemic approach to tackle CKD, based on mitigating the associated inflammatory, cell stress, and damage processes, has the potential to attenuate the effects of CKD, but it also preempts the development and progression of associated morbidities. In effect, this will enhance health span and compress the period of morbidity. Pharmacological, nutritional, and potentially lifestyle-based interventions are promising therapeutic avenues to achieve such a goal. In the present review, currents concepts of inflammation and oxidative damage as key patho-mechanisms in CKD are addressed. In particular, potential beneficial but also adverse effects of different systemic interventions in patients with CKD are discussed. Senotherapeutics, the nuclear factor erythroid 2-related factor 2-kelch-like ECH-associated protein 1 (NRF2-KEAP1) signaling pathway, the endocrine klotho axis, inhibitors of the sodium-glucose cotransporter 2 (SGLT2), and live bio-therapeutics have the potential to reduce the burden of CKD and improve quality of life, as well as morbidity and mortality, in this fragile high-risk patient group. Antioxid. Redox Signal. 35, 1426-1448.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care

